130 related articles for article (PubMed ID: 34165404)
21. Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents.
Kuang WB; Huang RZ; Qin JL; Lu X; Qin QP; Zou BQ; Chen ZF; Liang H; Zhang Y
Eur J Med Chem; 2018 Sep; 157():139-150. PubMed ID: 30092368
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and In Vitro Cytotoxicity and Antibacterial Activity of Novel 1,2,3-Triazol-5-yl-phosphonates.
Tripolszky A; Tóth E; Szabó PT; Hackler L; Kari B; Puskás LG; Bálint E
Molecules; 2020 Jun; 25(11):. PubMed ID: 32517229
[TBL] [Abstract][Full Text] [Related]
24. Predicting the cytotoxicity of disinfection by-products to Chinese hamster ovary by using linear quantitative structure-activity relationship models.
Qin LT; Zhang X; Chen YH; Mo LY; Zeng HH; Liang YP; Lin H; Wang DQ
Environ Sci Pollut Res Int; 2019 Jun; 26(16):16606-16615. PubMed ID: 30989598
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)nicotinamides as potential anticancer agents that inhibit tubulin polymerization.
Kamal A; Reddy NV; Nayak VL; Bolla NR; Subba Rao AV; Prasad B
Bioorg Med Chem; 2014 Jul; 22(13):3465-77. PubMed ID: 24835786
[TBL] [Abstract][Full Text] [Related]
26. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG
Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572
[TBL] [Abstract][Full Text] [Related]
27. In-vitro cytotoxicity and cell cycle analysis of two novel bis-1,2, 4-triazole derivatives: 1,4-bis[5-(5-mercapto-1,3,4-oxadiazol-2-yl-methyl)-thio-4-(p-tolyl)-1,2,4-triazol-3-yl]-butane (MNP-14) and 1,4-bis[5-(carbethoxy-methyl)-thio-4-(p-ethoxy phenyl)-1,2,4-triazol-3-yl]-butane (MNP-16).
Purohit MN; Panjamurthy K; Elango S; Hebbar K; Mayur YC; Raghavan SC
Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):873-85. PubMed ID: 22060552
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of 3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines as Bcl-2 inhibitory anticancer agents.
Hamdy R; Ziedan N; Ali S; El-Sadek M; Lashin E; Brancale A; Jones AT; Westwell AD
Bioorg Med Chem Lett; 2013 Apr; 23(8):2391-4. PubMed ID: 23474389
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, Cytotoxicity, ADMET and Molecular Docking Studies of Some Quinoline-Pyrimidine Hybrid Compounds: 3-(2-Amino-6-arylpyrimidin-4- yl)-4-hydroxy-1-methylquinolin-2(1H)-ones.
Toan DN; Thanh ND; Truong MX; Van DT
Med Chem; 2022; 18(1):36-50. PubMed ID: 33380305
[TBL] [Abstract][Full Text] [Related]
30. Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist.
Lee J; Seo HJ; Lee SH; Kim J; Jung ME; Lee SH; Song KS; Lee J; Kang SY; Kim MJ; Kim MS; Son EJ; Lee M; Han HK
Bioorg Med Chem; 2010 Sep; 18(17):6377-88. PubMed ID: 20673729
[TBL] [Abstract][Full Text] [Related]
31. DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.
Cano C; Barbeau OR; Bailey C; Cockcroft XL; Curtin NJ; Duggan H; Frigerio M; Golding BT; Hardcastle IR; Hummersone MG; Knights C; Menear KA; Newell DR; Richardson CJ; Smith GC; Spittle B; Griffin RJ
J Med Chem; 2010 Dec; 53(24):8498-507. PubMed ID: 21080722
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis, and Antitumor Activity of (E,Z)-1-(dihydrobenzofuran-5-yl)-3-phenyl-2-(1,2,4-triazol-1-yl)-2-propen-1-ones.
Li W; Yang ZH; Hu AX; Yan XW; Ding N; Ye J
Chem Biol Drug Des; 2015 Dec; 86(6):1339-50. PubMed ID: 26041467
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl)quinolin-2(1
El-Sheref EM; Bräse S; Tawfeek HN; Alasmary FA; Youssif BGM
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686105
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of some novel heterocylic compounds derived from 2-[3-(4-chlorophenyl)-5-(4-methoxybenzyl)-4H-1,2,4-triazol-4-yl]acetohydrazide and investigation of their lipase and α-glucosidase inhibition.
Bekircan O; Ülker S; Menteşe E
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):1002-9. PubMed ID: 25640970
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents.
Liu CF; Shen QK; Li JJ; Tian YS; Quan Z
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1111-1119. PubMed ID: 28791908
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II).
Yılmaz Ö; Bayer B; Bekçi H; Uba AI; Cumaoğlu A; Yelekçi K; Küçükgüzel ŞG
Med Chem; 2020; 16(6):735-749. PubMed ID: 31203805
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and anticonvulsant activity evaluation of novel 4-(4-substitutedphenyl)-3-methyl-1H-1,2,4-triazol-5(4H)-ones.
Zheng Y; Wang SB; Cao X; Liu DC; Shu B; Quan ZS
Drug Res (Stuttg); 2014 Jan; 64(1):40-6. PubMed ID: 23965799
[TBL] [Abstract][Full Text] [Related]
38. QSAR model for predicting the fungicidal action of 1,2,4-triazole derivatives against Candida albicans.
Singla RK; Bhat G V
J Enzyme Inhib Med Chem; 2010 Oct; 25(5):696-701. PubMed ID: 20429780
[TBL] [Abstract][Full Text] [Related]
39. Discovery and in vitro and in vivo profiles of N-ethyl-N-[2-[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]ethyl]-2-(2H-1,2,3-triazol-2-yl)-benzamide as a novel class of dual orexin receptor antagonist.
Suzuki R; Nozawa D; Futamura A; Nishikawa-Shimono R; Abe M; Hattori N; Ohta H; Araki Y; Kambe D; Ohmichi M; Tokura S; Aoki T; Ohtake N; Kawamoto H
Bioorg Med Chem; 2015 Mar; 23(6):1260-75. PubMed ID: 25693785
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
